Cargando…
Correction to: Low expression of TRAF3IP2-AS1 promotes progression of NONO-TFE3 translocation renal cell carcinoma by stimulating N(6)-methyladenosine of PARP1 mRNA and downregulating PTEN
Autores principales: | Yang, Lei, Chen, Yi, Liu, Ning, Shi, QianCheng, Han, Xiaodong, Gan, Weidong, Li, Dongmei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8442377/ https://www.ncbi.nlm.nih.gov/pubmed/34521439 http://dx.doi.org/10.1186/s13045-021-01153-8 |
Ejemplares similares
-
Low expression of TRAF3IP2-AS1 promotes progression of NONO-TFE3 translocation renal cell carcinoma by stimulating N(6)-methyladenosine of PARP1 mRNA and downregulating PTEN
por: Yang, Lei, et al.
Publicado: (2021) -
The suitability of NONO-TFE3 dual-fusion FISH assay as a diagnostic tool for NONO-TFE3 renal cell carcinoma
por: Liu, Ning, et al.
Publicado: (2020) -
Both SUMOylation and ubiquitination of TFE3 fusion protein regulated by androgen receptor are the potential target in the therapy of Xp11.2 translocation renal cell carcinoma
por: Liu, Ning, et al.
Publicado: (2022) -
5mC and H3K9me3 of TRAF3IP2 promoter region accelerates the progression of translocation renal cell carcinoma
por: Yang, Lei, et al.
Publicado: (2022) -
Postoperative recurrence of adult renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion
por: Wang, Zhen, et al.
Publicado: (2017)